CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

BACKGROUND: Accurate and early prognosis of disease is essential to clinical decision making, particularly in diseases, such as HCC, that are typically diagnosed at a late stage in the course of disease and therefore carry a poor prognosis. CDCA5 is a cell cycle regulatory protein that has shown pro...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Tian, Yunhong, Wu, Jianlin, Chagas, Cristian, Du, Yichao, Lyu, Huan, He, Yunhong, Qi, Shouliang, Peng, Yong, Hu, Jiani
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267780/
https://ncbi.nlm.nih.gov/pubmed/30497429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5072-4
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki